AlphaYouAL
Congress trade
Rep. Alan Lowenthal (D-CA) sold $15K-$50K of Bristol-Myers Squibb Company (BMY) stock
Alan Lowenthal, U.S. Representative (D-CA), disclosed a sale of Bristol-Myers Squibb Company (BMY) stock worth $15K-$50K in a STOCK Act filing on Oct 10, 2017.
The trade happened on Sep 25, 2017, 15 days before it was made public.
BMY has moved -3.2% since the trade date, from $63.19 to $61.15 (Oct 2, 2026 close).
- Traded
- Sep 25, 2017
- Disclosed
- Oct 10, 2017
- Filing delay
- 15 days
- Price since
- -3.2%
- Source
- STOCK Act disclosure
Other trades in this disclosure (7)
More BMY insider and Congress trades
From a public STOCK Act disclosure, linked above. Not investment advice, and not a recommendation to buy or sell.